









Indian pharma stocks drop after Trump asks innovative drugmakers to cut prices in US

ReutersAug 1, 2025 5:13 AM

Indian pharma stocks .NIPHARM drop 2.1%, top sectoral loser

President Trump sent letters to leaders of 17 major drugmakers outlining how they should slash U.S. prescription drug prices to match those paid overseas

While Indian drugmakers are not included in the list, it is a sentimental impact as price cuts by top innovative drugmakers could force smaller players to follow suit since it's a competitive industry, says Vishal Manchanda, pharma analyst at Systematix

Nineteen of 20 stocks on sub-index in red, with losses led by SUN, which is down 3.5%

"Sun Pharma SUN.NS is down the most because it has an exposure to innovative drugs and gets about 20% of its total sales from them," Manchanda says

Cipla CIPL.NS, Dr Reddy's REDY.NS decline 2.4% each

YTD, NIPHARM down 4.8% vs Nifty 50's .NSEI 4.7% climb

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Tradingkey

Recommended Articles

Pop Mart Revenue Tops 30 Billion Net Profit Surges 284%, Why Did Stock Price Plummet 15%?

TradingKey - On March 25, following the release of Pop Mart's (09992.HK) 2025 annual results, its Hong Kong-listed shares plummeted by as much as 15% intraday. Although the full-year performance was robust and generally aligned with market expectations, investor dissatisfaction was directly reflected in the stock price.

SpaceX IPO Approaches: Behind the $75 Billion Fundraising Rumors, What Is the Capital Market Betting On?

TradingKey - U.S. tech media outlet The Information reports that SpaceX plans to file an IPO prospectus with regulators as early as this week or next. Advisors expect the offering could raise more than $75 billion.

Ethereum Treasury Turn: Why Bitmine Stock is Breaking Away From the Crypto Pack

Bitmine leads the "Great Rotation" with an $11B Ethereum treasury and 93.8% margins. As the world’s largest corporate ETH holder, Bitmine is evolving from a miner into a DeFi powerhouse, offering diversified exposure to AI and staking yields in the 2026 digital economy.

Raising $10 Billion to Expand Capacity, Can SK Hynix Break the Memory Industry Landscape by Listing in the US?

TradingKey - South Korean memory giant SK Hynix is planning a U.S. listing through the issuance of American Depositary Receipts (ADRs), aiming to raise 10 trillion to 15 trillion KRW (approximately $6.7 billion to $10 billion).

AI Computing Power Ignites Storage Supercycle, Wedbush: Product Prices Surge Over 100%

TradingKey - A new industry report from prominent Wall Street investment bank Wedbush notes that explosive growth in global AI infrastructure development is triggering a supply-demand imbalance in the memory chip market. DRAM and NAND prices are projected to see "triple-digit gains" by the first half of 2026.

Tradingkey

KeyAI

